Back to Our Insights

Medtech Insights


Top ten observations from 2022 in life sciences digital and analytics

– Life sciences companies are making progress in adopting and deploying digital and analytics. But they can go further and faster... by heeding some lessons from the past few years.

How Daiichi Sankyo Europe drives growth with digital and analytics

– Digital and analytics can markedly improve life sciences companies’ engagement with customers. Daiichi Sankyo Europe’s... CEO Jan Van Ruymbeke explains the challenges to adopting digital and analytics and how his company overcame them.

How medtechs can meet industry demand for omnichannel engagement

– A McKinsey survey of more than 1,900 medtech leaders shows that their customers want more omnichannel engagement. We describe... five ways medtech companies can respond.

AI for medtech commercial growth: Five missteps to avoid

– Medtech companies are looking to AI and advanced analytics to help retool their commercial models to meet customers’ evolving... expectations—but common misunderstandings can delay progress.

The future of medtech sales is hybrid

– The medtech industry is at an inflection point in its adoption of remote-sales and support models. Leading companies are embracing... hybrid sales and raising the bar for others.

Out of the shadows: A brighter future for pharma technical development

– The sometimes-overlooked function of chemistry, manufacturing, and controls (CMC) has a rare opportunity to reimagine its role... and find innovative ways to improve and accelerate drug development.

Self-learning: The dawn of a new biomedical R&D paradigm

– Science and technology are driving breakthroughs at each stage of the biomedical R&D value chain. Enhancing feedback loops... among them could unleash a self-learning model that would benefit patients.

Innovation sourcing in biopharma: Four practices to maximize success

– Biopharma companies’ pipelines are full of assets they source externally to access innovation. Four practices will help... ensure their investments flourish at a time of fierce competition.

Accelerating growth in medtech: The next surge in portfolio moves

– Large medtech companies are struggling with growth challenges and stagnant valuations. Could M&A and divestitures reset the... trajectory?

How medtech companies can create value with new-business building

– Medtech industry senior executives recently convened to discuss new-business building. Their experiences illuminate what it can... do for companies, why it’s so difficult, and how to get it right.

From extreme to mainstream: The future of aesthetics injectables

– McKinsey research shows that the global aesthetics injectables market could grow by 12 to 14 percent a year over the next five... years if manufacturers and providers capitalize on the underlying trends.
Sorry, we couldn't find any results. Try removing some filters.

Related Insight

Scanning the future of medical imaging

December 2018 – Innovation, new business models, and new technologies are driving change in the medical device industry. This article maps start-ups and trends shaping the future of medical imaging, identifying clusters of technology and their growth prospects, as well as highlighting the implications these may have.